Ascrolimus
Alternative Names: A-86281; ABT 281Latest Information Update: 22 Jan 2013
At a glance
- Originator Abbott Laboratories
- Class Lactones; Macrolides; Skin disorder therapies
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Atopic dermatitis; Skin disorders
Most Recent Events
- 02 Jan 2013 Abbott separates its pharmaceuticals business to new company called AbbVie
- 15 Apr 2004 No development reported - Preclinical for Atopic dermatitis in USA (Topical)
- 15 Apr 2004 No development reported - Preclinical for Skin disorders in USA (Topical)